science
Study Links Memory Concerns and pTau181 Protein to Alzheimer’s at Age 45
Researchers analyzing data from more than 1,000 people around age 45 found that self-reported memory problems combined with elevated pTau181 protein levels may indicate Alzheimer’s risk up to two decades before typical diagnosis.
May 24, 12:20 PM·1m read1 source
New York PostAudio version
Tap play to generate a narrated version.
Developing·Limited corroboration so far. This page will refresh as more sources emerge.
A study of more than 1,000 participants around age 45 identified two potential early indicators of Alzheimer’s disease: self-reported memory concerns and elevated levels of the protein pTau181. 7 million Americans and may begin accumulating biological markers long before cognitive decline becomes noticeable.
Researchers reported that pTau181, a toxic protein associated with Alzheimer’s, appeared in combination with memory complaints at midlife, suggesting the protein may start building up earlier than previously understood. The same study noted that another protein, p-tau217, can be measured through a blood test and follows a consistent pattern that precedes memory loss; older adults showed faster symptom onset once p-tau217 levels became abnormal.
Identifying these markers at younger ages could allow treatments that slow disease progression to begin earlier, when they are considered most effective. Screening for pTau181 alongside memory reports may also help differentiate early Alzheimer’s changes from normal aging and support preventive steps such as exercise and increased social interaction.
